プロトオンコゲンbcl-2は,アポプトーシスによる神経縮因子依存ニューロンを選択的に救出することができます
T E Allsopp1, S Wyatt, H F Paterson
1School of Biological and Medical Sciences, St. Andrews, Fife, Scotland.
Cell
|April 23, 1993
まとめ
bcl-2遺伝子製品は,一部のニューロンにおけるアポトーシスを防ぐことができますが,すべてではありません. 特定の神経栄養素因子の影響を受け,異なる神経死経路が存在する.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
背景:
- アポトーシスは,発達中の細胞数を調節するために不可欠です.
- bcl-2遺伝子製品は,骨髄性およびリンパ性細胞におけるアポトーシスを抑制する.
- ニューロン細胞死におけるbcl-2の役割を理解することは不可欠です.
研究 の 目的:
- ニューロンのアポトーシスの予防におけるbcl-2の機能を調査する.
- ニューロントロフィック因子欠乏によって引き起こされる死亡からニューロンを救うことができるかどうかを判断する.
- 異なるニューロン死亡経路を特定するために.
主な方法:
- 胚性ニューロンにbcl-2発現ベクトルのマイクロインジェクション.
- アポトーシスを誘発するニューロトロフィック因子の剥奪.
- センサリーニューロンのシリアニューロトロフィック因子 (CNTF) への曝露.
主要な成果:
- bcl-2は,神経成長因子ファミリーのメンバーに依存する感覚神経細胞を救出しました.
- bcl-2は,シリアニューロントロフィック因子 (CNTF) に依存するシリアニューロンを救出しなかった.
- 感覚ニューロンは,CNTF曝露後にbcl-2に耐性を持つようになった.
結論:
- 少なくとも2つの異なる神経死経路が存在する.
- ニューロンアポトーシスのbcl-2への感受性は,関連する特定の神経栄養素因子に依存します.
- これらの発見は,神経細胞の生存と死亡の規制の複雑さを強調しています.
関連する概念動画
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


